Pensions & Investments Logo
ETF Exchange > MRNX ETF

MRNX - ETF Fact Sheet

Defiance Daily Target 2X Long MRNA ETF - USD

Fund Identification

Ticker

MRNX

ISIN

US88636X8157

Main Metrics

Price

$31.57

Expense Ratio

1.31%

AuM

$2.84M

Tracking Difference

%

Ratings

Trackinsight rating

N/A

Official Investment Strategy

The Defiance Daily Target 2X Long MRNA ETF (MRNX) provides investors with amplified long exposure to Moderna, Inc. (NASDAQ: MRNA), a biotechnology company focused on the development and commercialization of messenger RNA (mRNA)–based medicines and vaccines. Moderna’s proprietary mRNA platform enables the rapid design and production of therapies across a range of disease areas, including infectious diseases and other unmet medical needs.

MRNX's historical prices, performance, and flows

020406080100%
1m returns
13%
1m flows
-$1M
* Net total returns
All data as of 17 July 2026

The ETF Exchange is brought to you by

State Street
With data and analysis by
Trackinsight
See all MRNX data with a
free P&I Online account
Enjoy unlimited ETF searches and access to tear-sheets of over 4,000 North-American funds.

MRNX's characteristics

Manager statistics

90 funds, $10.26Bn in AUM

Benchmark

MRNA - Price

Replication method

Indirect

Asset class

Equity

Dividend policy

Distributing

MRNX's exposure

This ETF provides synthetic exposure. It does not hold the securities of the index directly so we cannot display its exposure breakdown.

80